XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
We break down Which Index Funds To Buy For Retirement 2024, focusing on costs, diversification, and track records to help you decide.
24,904 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
The iShares MSCI Japan ETF is at the center of a major market overhaul in Japan, delivering broad exposure to a shift...
A high-profile hedge fund billionaire made bold moves, piling into Amazon and Microsoft while slashing a top AI stock...
May data from the NAHB Eye on Housing show input costs for residential construction accelerated, led by energy prices...
The full text of a U.S.-Iran peace deal is public, triggering market swings and mixed ally responses. This article br...
The Nasdaq Composite steadied amid a breathless week of data, with investors weighing slowing growth against resilien...
SM Energy surged 37% year-to-date after finalizing its Civitas Resources merger, but a quarterly miss underscored lev...
Equities drift lower as oil prices jump, lifting energy shares and weighing on risk appetite. The S&P 500 retreats wh...
A hotter-than-expected May PPI rekindles wholesale inflation back focus, sending Bitcoin lower as traders reassess in...
Reggora has earned verification from Fannie Mae and Freddie Mac for its UAD 3.6 forms, signaling a shift toward a sin...
River Road Asset Management just added a notable new position in AptarGroup, acquiring 917,670 shares valued at about...
ShoreHaven Wealth Partners is shifting focus from a U.S.-centric mix to international exposure via an active rotation...